Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
What dose would you give for LRC for a PEcoma (perivascular epitheliod cell tumor) of the anal canal?
Related Questions
How would you treat synchronous high-risk prostate and rectal adenocarcinomas in an elderly man where the rectal cancer was resected secondary to obstruction (T3N0)?
Do you consider any "favorable" subset of patients with stage IV pancreatic cancer to be candidates for local pre-operative CRT and surgical resection?
What are best practices for oncologists during the national platinum shortage?
How would you adjust your CTV for a locally advanced rectal cancer case with invasion of the prostate?
How would you treat a patient with a synchronous T1N2 non-small cell lung cancer and a T3N1 mid-rectal adenocarcinoma (MMR intact)?
Would you offer adjuvant chemotherapy after SBRT for biopsy proven sub centimeter metastatic pulmonary nodule from rectal cancer?
How often do you see pseudoprogession in pancreatic cancer after SBRT, and how do you manage it if the patient is planed for surgical exploration?
For inoperable cholangiocarcinoma, do you recommend up-front chemotherapy prior to offering SBRT or combination chemoradiation?
A patient has unresectable, node-positive, oligometastatic gallbladder cancer -- when would you offer radiation?
Do you ever utilize short-course radiation when lateral pelvic (extra-mesorectal) lymph nodes are involved?
